The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials

British Journal of Cancer, Published online: 19 May 2020; doi:10.1038/s41416-020-0894-7The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials

Source: British Journal of Cancer - May 18, 2020 Category: Cancer & Oncology Authors: Giovanni Fuc à Vincenzo Guarini Carlotta Antoniotti Federica Morano Roberto Moretto Salvatore Corallo Federica Marmorino Sara Lonardi Lorenza Rimassa Andrea Sartore-Bianchi Beatrice Borelli Marco Tampellini Sara Bustreo Matteo Claravezza Alessandra Bocca Source Type: research